Pediculosis Capitis
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ParaPROIN - Carmel
2 programs2
NatrOVA Creme Rinse - 1%Phase 21 trial
Spinosad Creme Rinse - Vehicle ControlPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsVamousse Spray 'n' Go
ParaPRONatrOVA Creme Rinse - 1%
ParaPROSpinosad Creme Rinse - Vehicle Control
Clinical Trials (3)
Total enrollment: 118 patients across 3 trials
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
Start: Dec 2022Est. completion: Mar 202358 patients
Phase 4Completed
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
Start: Mar 2007Est. completion: Apr 200724 patients
Phase 2Completed
A Pilot Dose Ranging Study of Spinosad Creme Rinse
Start: Sep 2005Est. completion: Nov 200536 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.